Important statistical considerations in the evaluation of post-market studies to assess whether opioids with abuse-deterrent properties result in reduced abuse in the community.

Autor: By K; US Food and Drug Administration, Silver Spring, MD, USA., McAninch JK; US Food and Drug Administration, Silver Spring, MD, USA., Keeton SL; US Food and Drug Administration, Silver Spring, MD, USA., Secora A; US Food and Drug Administration, Silver Spring, MD, USA., Kornegay CJ; US Food and Drug Administration, Silver Spring, MD, USA., Hwang CS; US Food and Drug Administration, Silver Spring, MD, USA., Ly T; US Food and Drug Administration, Silver Spring, MD, USA., Levenson MS; US Food and Drug Administration, Silver Spring, MD, USA.
Jazyk: angličtina
Zdroj: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2018 May; Vol. 27 (5), pp. 473-478. Date of Electronic Publication: 2017 Aug 23.
DOI: 10.1002/pds.4287
Abstrakt: Purpose: Abuse, misuse, addiction, overdose, and death associated with non-medical use of prescription opioids have become a serious public health concern. Reformulation of these products with abuse-deterrent properties is one approach for addressing this problem. FDA has approved several extended-release opioid analgesics with abuse-deterrent labeling, the bases of which come from pre-market studies. As all opioid analgesics must be capable of delivering the opioid in order to reduce pain, abuse-deterrent properties do not prevent abuse, nor do pre-market evaluations ensure that there will be reduced abuse in the community. Utilizing data from various surveillance systems, some recent post-market studies suggest a decline in abuse of extended-release oxycodone after reformulation with abuse-deterrent properties. We discuss challenges stemming from the use of such data.
Methods: We quantify the relationship between the sample, the population, and the underlying sampling mechanism and identify the necessary conditions if valid statements about the population are to be made. The presence of other interventions in the community necessitates the use of comparators. We discuss the principles under which the use of comparators can be meaningful.
Conclusions: Results based on surveillance data need to be interpreted with caution as the underlying sampling mechanisms can bias the results in unpredictable ways. The use of comparators has the potential to disentangle the effect due to the abuse-deterrence properties from those due to other interventions. However, identifying a comparator that is meaningful can be very difficult.
(Published 2017. This article is a U.S. Government work and is in the public domain in the USA.)
Databáze: MEDLINE
Externí odkaz: